Cornerstone Investment Partners’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,763
Closed -$166K 217
2025
Q1
$166K Sell
12,763
-1,306
-9% -$17.3K 0.01% 152
2024
Q4
$180K Buy
14,069
+3
+0% +$36 0.01% 225
2024
Q3
$157K Buy
+14,066
New +$155K 0.01% 205
2024
Q2
Sell
-11,421
Closed -$142K 239
2024
Q1
$142K Buy
11,421
+151
+1% +$1.97K 0.01% 228
2023
Q4
$158K Hold
11,270
0.01% 211
2023
Q3
$166K Buy
+11,270
New +$159K 0.01% 156
2023
Q2
Sell
-12,830
Closed -$126K 217
2023
Q1
$126K Sell
12,830
-1,918
-13% -$20.5K 0.01% 192
2022
Q4
$157K Sell
14,748
-500
-3% -$5.81K 0.01% 199
2022
Q3
$159K Buy
+15,248
New +$199K 0.01% 168

Other funds holding DVAX

Cornerstone Investment Partners's DVAX Position: Q2 2025 in Review

Cornerstone Investment Partners sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 12,763 shares — an estimated $166K sold.

Cornerstone Investment Partners first reported a position in DVAX in Q3 2022 and held it in 9 quarters. The position peaked at $180K in Q4 2024. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Cornerstone Investment Partners reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Cornerstone Investment Partners sold 12,763 Dynavax Technologies shares in Q2 2025, an estimated $166K.
  • Cornerstone Investment Partners first reported a position in Dynavax Technologies in Q3 2022 and held it in 9 quarters.
  • Cornerstone Investment Partners's Dynavax Technologies position peaked at $180K in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Cornerstone Investment Partners's 13F filing for Q2 2025, filed 6 Aug 2025.